查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1465569

脊椎骨刺激器市場- 按設備類型{侵入式、非侵入式[脈衝電磁場設備、電容耦合(CC) 設備、組合（電）磁場(CMF) 設備]}、最終用途（醫院、ASC） -全球2024 - 2032 年預測

Spine Bone Stimulators Market - By Device Type {Invasive, Non-Invasive [Pulsed Electromagnetic Field Devices, Capacitive Coupling (CC) Devices, Combined (Electro) Magnetic Field (CMF) Devices]}, End-use (Hospitals, ASCs) - Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於領先公司的批准和專利不斷增加，2024 年至 2032 年間，全球脊椎骨刺激器市場的複合年成長率將超過 5.7%。由於脊椎疾病持續困擾著大部分人群，創新的解決方案對於有效治療至關重要。

例如，2022 年 8 月，醫療器材公司 Theragen 很高興地宣布授予一項美國專利，認可其在創建 ActaStim-S 脊椎融合骨生長刺激器系統方面的創新策略。 ActaStim-S 是數十年來首款新型脊椎融合刺激器，將經過臨床驗證的治療刺激與現代設計元素和富含資料的綜合數位健康平台相結合。

領先公司正大力投資研發，將新型骨刺激技術推向市場。這些進步提高了患者的治療效果，同時解決了脊椎護理中未滿足的醫療需求。隨著監管部門的批准和專利推動市場競爭力，公司準備推出各種骨骼刺激器，以滿足不同患者的需求。創新的激增凸顯了研發在塑造脊椎骨刺激器市場未來的關鍵作用。

整個脊椎骨刺激器產業根據設備類型、最終用途和地區進行分類。

侵入性脊椎骨刺激器領域將在 2024 年至 2032 年間實現顯著成長。當患者尋求退化性椎間盤疾病和脊椎骨折等脊椎疾病的解決方案時，侵入性脊椎骨刺激器提供了一種有前途的治療選擇。它們加速癒合和改善脊椎穩定性的能力使其在醫療保健提供者和患者中廣受歡迎，從而刺激了脊椎骨刺激器市場的需求。

從 2024 年到 2032 年，專科診所領域的脊椎骨刺激器市場佔有率將實現顯著的複合年成長率。當患者尋求適合其特定需求的綜合治療方案時，專科診所提供治療脊椎疾病的專業知識和個人化護理。他們對創新療法和以患者為中心的方法的重視導致對脊椎骨刺激器的需求增加，反映出專業醫療服務在解決脊椎相關問題方面日益重要。

歐洲脊椎骨刺激器市場從 2024 年到 2032 年將呈現出值得稱讚的複合年成長率。歐洲醫療保健系統優先考慮使用先進的醫療技術，包括脊椎骨刺激器，以改善患者的治療結果。此外，該地區對研究和開發的重視促進了新型骨刺激療法的引入，進一步推動了市場成長。隨著患者和醫療保健提供者尋求脊椎疾病的有效解決方案，歐洲對脊椎骨刺激器的需求持續成長，塑造了脊椎護理的模式。

例如，2022年2月，洛桑大學醫院的Jocelyne Bloch博士和瑞士聯邦理工學院的Gregoire Courtine進行的一項脊髓刺激研究取得了突破性結果。週一發表在《自然醫學》雜誌上的 STIMO 臨床試驗重新利用了最初旨在緩解疼痛的現有技術，專門針對脊神經根，改進了脊椎刺激方法。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 脊柱畸形發生率上升
      • 微創手術的需求不斷增加
      • 設備技術進步
    • 產業陷阱與挑戰
      • 設備成本高且報銷率低
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 報銷場景
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按設備類型，2018 年 - 2032 年

  • 主要趨勢
  • 侵入式脊椎骨刺激器
  • 非侵入性脊椎骨刺激器
    • 脈衝電磁場裝置
    • 電容耦合 (CC) 裝置
    • 組合（電）磁場 (CMF) 設備

第 6 章：市場估計與預測：依最終用途，2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他最終用戶

第 7 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 8 章：公司簡介

  • Bioventus
  • Elizur Corporation
  • Enovis (DJO Global, Inc.)
  • IGEA S.p.A.
  • Medtronic plc
  • Orthofix Medical Inc.
  • Ossatec Benelux BV
  • Synergy Orthopedics
  • Theragen, Inc. (Neurotech NA Inc.)
  • ZimVie Inc
簡介目錄
Product Code: 8314

Global Spine Bone Stimulators Market will witness over 5.7% CAGR between 2024 and 2032 due to increasing approvals and patents from leading companies. As spinal conditions continue to afflict a large segment of the population, innovative solutions are imperative for effective treatment.

For instance, in August 2022, Theragen, a medical device company, was delighted to announce the granting of a U.S. Patent recognizing its inventive strategy in creating the ActaStim-S Spine Fusion Bone Growth Stimulator system. Representing the first new Spine Fusion Stimulator in decades, ActaStim-S combined clinically validated therapeutic stimulation with contemporary design elements and a comprehensive digital health platform enriched with data.

Leading firms are investing extensively in research and development to bring novel bone stimulation technologies to market. These advancements enhance patient outcomes while addressing unmet medical needs in spine care. With regulatory approvals and patents driving market competitiveness, companies are poised to introduce a wide array of bone stimulators catering to diverse patient requirements. This surge in innovation underscores the pivotal role of research and development in shaping the future of the Spine Bone Stimulators Market.

The overall Spine Bone Stimulators Industry is classified based on the device type, end-use, and region.

The invasive spine bone stimulators segment will record significant growth from 2024 to 2032. These advanced medical devices are designed to stimulate bone growth and promote fusion in the spine through surgical implantation. As patients seek solutions for spinal conditions such as degenerative disc disease and spinal fractures, invasive spine bone stimulators offer a promising treatment option. Their ability to accelerate healing and improve spinal stability drives their popularity among healthcare providers and patients alike, fueling demand in the Spine Bone Stimulators Market.

Spine bone stimulators market share from the specialty clinics segment will register a noteworthy CAGR from 2024 to 2032. These clinics focus on providing specialized care for spinal conditions, including the use of bone stimulators to promote healing and fusion. As patients seek comprehensive treatment options tailored to their specific needs, specialty clinics offer expertise and personalized care in managing spinal disorders. Their emphasis on innovative therapies and patient-centric approaches contributes to the increased demand for spine bone stimulators, reflecting the growing importance of specialized healthcare services in addressing spine-related issues.

Europe spine bone stimulators market will showcase a commendable CAGR from 2024 to 2032. With a growing aging population and increasing prevalence of spinal disorders, there is a heightened demand for innovative treatment options. European healthcare systems prioritize access to advanced medical technologies, including spine bone stimulators, to improve patient outcomes. Additionally, the region's emphasis on research and development fosters the introduction of novel bone stimulation therapies, further driving market growth. As patients and healthcare providers seek effective solutions for spinal conditions, the demand for spine bone stimulators in Europe continues to rise, shaping the landscape of spine care.

For instance, in February 2022, A spinal cord stimulation study conducted by Dr. Jocelyne Bloch of Lausanne University Hospital and Gregoire Courtine of the Swiss Federal Institute of Technology yielded groundbreaking results. Published in the journal Nature Medicine on Monday, the STIMO clinical trial repurposed existing technology, originally aimed at pain relief, to specifically target spinal nerve roots, improving spine stimulation methods.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rise in incidence of spinal deformities
      • 3.2.1.2 Increasing demand for minimally invasive procedures
      • 3.2.1.3 Technological advancements in devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High device cost and lack of reimbursement rates
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter's analysis
    • 3.7.1 Supplier power
    • 3.7.2 Buyer power
    • 3.7.3 Threat of new entrants
    • 3.7.4 Threat of substitutes
    • 3.7.5 Industry rivalry
  • 3.8 PESTEL analysis
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Invasive spine bone stimulators
  • 5.3 Non-invasive spine bone stimulators
    • 5.3.1 Pulsed electromagnetic field devices
    • 5.3.2 Capacitive coupling (CC) devices
    • 5.3.3 Combined (electro) magnetic field (CMF) devices

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Specialty clinics
  • 6.4 Ambulatory surgical centers
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Bioventus
  • 8.2 Elizur Corporation
  • 8.3 Enovis (DJO Global, Inc.)
  • 8.4 IGEA S.p.A.
  • 8.5 Medtronic plc
  • 8.6 Orthofix Medical Inc.
  • 8.7 Ossatec Benelux BV
  • 8.8 Synergy Orthopedics
  • 8.9 Theragen, Inc. (Neurotech NA Inc.)
  • 8.10 ZimVie Inc